Citations

Mayo Clinic

Showing 10 of 108602 citations.

Comparison of Three Information Sources for Smoking Information in Electronic Health Records
Wang, Liwei , Ruan, Xiaoyang , Yang, Ping , Liu, Hongfang

Cancer Informatics | October 9, 2017 | Volume: 15 | Issue: No issue available | Pages: CIN.S40604

10.4137/cin.s40604 | PMID 27980387 Get It

Objective The primary aim was to compare independent and joint performance of retrieving smoking status through different sources, including narrative text processed by natural language processing (NLP), patient-provided information (PPI), and diagnosis codes (ie, International Classification of Diseases, Ninth Revision [ICD-9]). We also compared the performance of retrieving smoking strength information (ie, heavy/light smoker) from narrative text and PPL Materials and Methods Our study leveraged an existing lung cancer cohort for smoking status, amount, and strength information, which was manually chart-reviewed. On the NLP side, smoking-related electronic medical record (EMR) data were retrieved first. A pattern-based smoking information extraction module was then implemented to extract smoking-related information. After that, heuristic rules were used to obtain smoking status-related information. Smoking information was also obtained from structured data sources based on diagnosis codes and PPI. Sensitivity, specificity, and accuracy were measured using patients with coverage (ie, the proportion of patients whose smoking status/strength can be effectively determined). Results NLP alone has the best overall performance for smoking status extraction (patient coverage: 0.88; sensitivity: 0.97; specificity: 0.70; accuracy: 0.88); combining PPI with NLP further improved patient coverage to 0.96. ICD-9 does not provide additional improvement to NLP and its combination with PPI. For smoking strength, combining NLP with PPI has slight improvement over NLP alone. Conclusion These findings suggest that narrative text could serve as a more reliable and comprehensive source for obtaining smoking-related information than structured data sources. PPI, the readily available structured data, could be used as a complementary source for more comprehensive patient coverage.
Palliation Versus Dialysis for End-Stage Renal Disease in the Oldest Old: What are the Considerations?
Walton, Lyle, Shumer, Gregory D, Suh, Theodore T., Thorsteinsdottir, Bjorg , Shumer, Gregory, Swetz, Keith M.

Palliative Care: Research and Treatment | October 9, 2017 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/1178224217735083 | PMID 29051704 Get It

As the US population continues to age, new cases of end-stage renal disease (ESRD) in individuals, aged 85 years or older (the oldest old), are increasing. Many patients who begin hemodialysis despite questionable benefit may struggle with high symptom burden and rapid functional decline. This article reviews the history regarding the funding and development of the Medicare ESRD program, reviews current approaches to the oldest old with ESRD, and considers strategies to improve the management approach of this vulnerable population.
Author response: Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice
Paschall, Sarah A. , MacIsaac, Sarah E, Kuhlmann, Naila , Kadgien, Chelsie , Fox, Jesse D. , Khinda, Jaskaran, Mitchell, Emma , Bergeron, Sabrina , Melrose, Heather L. , Milnerwood, Austen J. , Volta, Mattia , Beccano-Kelly, Dayne , Cataldi, Stefano , Tatarnikov, Igor , Farrer, Matthew J.

No container title available | October 9, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.28377.016 Get It

Physiological Dead Space and Arterial Carbon Dioxide Contributions to Exercise Ventilatory Inefficiency in Patients with Reduced or Preserved Ejection Fraction Heart Failure
Iterson, Erik H. Van , Johnson, Bruce D. , Borlaug, Barry A. , Olson, Thomas P. , Van Iterson, Erik H , Borlaug, Barry A

European Journal of Heart Failure | October 8, 2017 | Volume: 19 | Issue: 12 | Pages: 1675-1685

10.1002/ejhf.913 | PMID 28990307 Get It

Abstract Aims Patients with heart failure (HF) with reduced (HFrEF) or preserved (HFpEF) ejection fraction demonstrate an increased ventilatory equivalent for carbon dioxide (V̇E/V̇CO2) slope. The physiological correlates of the V̇E/V̇CO2 slope remain unclear in the two HF phenotypes. We hypothesized that changes in the physiological dead space to tidal volume ratio (VD/VT) and arterial CO2 tension (PaCO2) differentially contribute to the V̇E/V̇CO2 slope in HFrEF vs. HFpEF. Methods and results Adults with HFrEF (n = 32) and HFpEF (n = 27) [mean ± standard deviation (SD) left ventricular ejection fraction: 22 ± 7% and 61 ± 9%, respectively; mean ± SD body mass index: 28 ± 4 kg/m2 and 33 ± 6 kg/m2, respectively; P < 0.01] performed cardiopulmonary exercise testing with breath-by-breath ventilation and gas exchange measurements. PaCO2 was measured via radial arterial catheterization. We calculated the V̇E/V̇CO2 slope via linear regression, and VD/VT = 1 − [(863 × V̇CO2)/(V̇E × PaCO2)]. Resting VD/VT (0.48 ± 0.08 vs. 0.41 ± 0.11; P = 0.04), but not PaCO2 (38 ± 5 mmHg vs. 40 ± 3 mmHg; P = 0.21) differed between HFrEF and HFpEF. Peak exercise VD/VT (0.39 ± 0.08 vs. 0.32 ± 0.12; P = 0.02) and PaCO2 (33 ± 6 mmHg vs. 38 ± 4 mmHg; P < 0.01) differed between HFrEF and HFpEF. The V̇E/V̇CO2 slope was higher in HFrEF compared with HFpEF (44 ± 11 vs. 35 ± 8; P < 0.01). Variance associated with the V̇E/V̇CO2 slope in HFrEF and HFpEF was explained by peak exercise VD/VT (R2 = 0.30 and R2 = 0.50, respectively) and PaCO2 (R2 = 0.64 and R2 = 0.28, respectively), but the relative contributions of each differed (all P < 0.01). Conclusions Relationships between the V̇E/V̇CO2 slope and both VD/VT and PaCO2 are robust, but differ between HFpEF and HFrEF. Increasing V̇E/V̇CO2 slope appears to be strongly explained by mechanisms influential in regulating PaCO2 in HFrEF, which contrasts with the strong role of increased VD/VT in HFpEF.
Genomic Triangulation and Coverage Analysis in Whole-Exome Sequencing–Based Molecular Autopsies
Shanks, Garrett W., Tester, David J. , Nishtala, Sneha, Evans, Jared M., Ackerman, Michael J.

Circulation: Cardiovascular Genetics | October 7, 2017 | Volume: 10 | Issue: 5 | Pages: No page available

10.1161/circgenetics.117.001828 | PMID 28986455 Get It

Background— WEMA (Whole-Exome Molecular Autopsy) and surveillance of cardiac channelopathy and cardiomyopathy genes represents the latest molecular autopsy for sudden death in the young (SDY). To date, the majority of WEMA has been performed on the SDY case only. Methods and Results— We performed whole-exome sequencing and nucleotide-level coverage analysis on 28 SDY cases (18.4±7.8 years) and their parents to determine the inheritance patterns of ultrarare, nonsynonymous variants in 99 sudden death–susceptibility genes. Nonsynonymous variants were adjudicated using the American College of Medical Genetics guidelines. Overall, 17 sudden death–susceptibility gene variants were identified in 12 of 28 (43%) SDY cases. On the basis of the American College of Medical Genetics guidelines, 6 of 28 (21%) cases had a pathogenic or likely pathogenic nonsynonymous variant with 3 (50%) being de novo. Two nonsynonymous variants would not have been elevated to likely pathogenic status without knowing their de novo status. Whole-exome sequencing reached a read depth of 10× across 90% of nucleotides within sudden death–susceptibility genes in 100% of parental exomes from fresh blood draw, compared with only 82% of autopsy-sourced SDY exomes. Conclusions— An SDY-parent, trio-based WEMA may be an effective way of elucidating a monogenic cause of death and bringing clarity to otherwise ambiguous variants. If other studies confirm this relatively high rate of SDY cases stemming from de novo mutations, then the WEMA should become even more cost-effective given that the decedent’s first-degree relatives should only need minimal cardiological evaluation. In addition, autopsy-sourced DNA demonstrated strikingly lower whole-exome sequencing coverage than DNA from fresh blood draw.
Loss of FOXO1 Cooperates with TMPRSS2–ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion
Yang, Yinhui , Blee, Alexandra M. , Wang, Dejie , An, Jian , Pan, Yunqian , Yan, Yuqian , He, Yundong , Dugdale, Joseph , Hou, Xiaonan , Zhang, Jun , Weroha, S. John , Zhu, Wei‐Guo , Wang, Yanru , DePinho, Ronald A. , Xu, Wanhai , DePinho, Ronald A , Ma, Tao , Huang, Haojie

Cancer Research | October 6, 2017 | Volume: 77 | Issue: 23 | Pages: 6524-6537

10.1158/0008-5472.can-17-0686 | PMID 28986382 Get It

Abstract E26 transformation-specific transcription factor ERG is aberrantly overexpressed in approximately 50% of all human prostate cancer due to TMPRSS2-ERG gene rearrangements. However, mice with prostate-specific transgenic expression of prostate cancer–associated ERG alone fail to develop prostate cancer, highlighting that ERG requires other lesions to drive prostate tumorigenesis. Forkhead box (FOXO) transcription factor FOXO1 is a tumor suppressor that is frequently inactivated in human prostate cancer. Here, we demonstrate that FOXO1, but not other FOXO proteins (FOXO3 and FOXO4), binds and inhibits the transcriptional activity of prostate cancer–associated ERG independently of FOXO1 transcriptional activity. Knockdown of endogenous FOXO1 increased invasion of TMPRSS2–ERG fusion–positive VCaP cells, an effect completely abolished by ERG knockdown. Patient specimen analysis demonstrated that FOXO1 and ERG protein expression inversely correlated in a subset of human prostate cancer. Although human ERG transgene expression or homozygous deletion of Foxo1 alone in the mouse prostate failed to promote tumorigenesis, concomitant ERG transgene expression and Foxo1 deletion resulted in upregulation of ERG target genes, increased cell proliferation, and formation of high-grade prostatic intraepithelial neoplasia. Overall, we provide biochemical and genetic evidence that aberrantly activated ERG cooperates with FOXO1 deficiency to promote prostate tumorigenesis and cell invasion. Our findings enhance understanding of prostate cancer etiology and suggest that the FOXO1–ERG signaling axis can be a potential target for treatment of prostate cancer. Cancer Res; 77(23); 6524–37. ©2017 AACR.
Effect of Body Position on Epsicleral Venous Pressure in Healthy Subjects
Arora, Nitika, McLaren, Jay W. , Hodge, David O. , Sit, Arthur J. , Sit, Arthur J

Investigative Opthalmology & Visual Science | October 6, 2017 | Volume: 58 | Issue: 12 | Pages: 5151

10.1167/iovs.17-22154 | PMID 28986593 Get It

Comparison of Methods for Analyzing Human Adipose Tissue Macrophage Content
Morgan‐Bathke, Maria , Harteneck, Debra A., Jaeger, Philippa, Søndergaard, Esben , Karwoski, R., Ycaza, Ana Espinosa De, Carranza-Leon, Barbara Gisella , Faubion, William A. , Oliveira, André M. , Jensen, Michael D. , Harteneck, Debra, Karwoski, Ron, Espinosa De Ycaza, Ana, Carranza-Leon, B Gisella

Obesity | October 6, 2017 | Volume: 25 | Issue: 12 | Pages: 2100-2107

10.1002/oby.22012 | PMID 28985040 Get It

ObjectiveThe relationship between inflammation, obesity, and adverse metabolic conditions is associated with adipose tissue macrophages (ATM). This study compared the measurements of human ATM using flow cytometry, immunohistochemistry (IHC), and real‐time polymerase chain reaction (RT‐PCR) of ATM markers.MethodsA new software program (AMCounter) was evaluated to help measure ATM using IHC, and this was compared to flow cytometry and RT‐PCR.ResultsIHC had good intraindividual reproducibility for total (CD68), proinflammatory (CD14), and anti‐inflammatory (CD206) ATM. The AMCounter improved interreader agreement and was more time efficient. Flow cytometry had acceptable intraindividual reproducibility for the percentage of CD68+ cells that were CD14+ or CD206+, but not for ATMs per gram of tissue. ATMs per gram of tissue was much greater using IHC than flow cytometry. The flow cytometry and IHC measures of ATM from the same biopsies were not correlated. There were statistically significant correlations between RT‐PCR CD68 and IHC CD68, CD14, and CD206 ATMs per 100 adipocytes. Also of interest were statistically significant correlations between RT‐PCR CD68 and IHC CD68, CD14, and adipose flow cytometry measures of CD68+, CD68+/CD14+, and CD68+/CD206+ ATMs per gram of tissue.ConclusionsThe AMCounter software helps provide reproducible and efficient measures of IHC ATMs. Flow cytometry, IHC, and RT‐PCR measures of adipose inflammation provide somewhat different information.